Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada. The company offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, as well as medical and fibre-optic delivery devices. It exports its products to the United States. The company was formerly known as Aquarius Coatings, Inc. and changed its name to Aquarius Surgical Technologies Inc. in March 2017. Aquarius Surgical Technologies Inc. was incorporated in 1986 and is based in Toronto, Canada.…
Aquarius Surgical Technologies (CNSX: ASTI) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.
The shares were at 0.0100 CAD on 19 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 0.0100 CAD to 0.0150 CAD, and it trades at the bottom of that range.
Its market capitalisation is 275.99K CAD.
Aquarius Surgical Technologies reports return on equity of 10.1%, an operating margin of -243.6% and revenue up 1.1% year over year.
Its debt exceeds its cash by 7.03M CAD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.
No upcoming events tracked.